Morgan Stanley raises MetLife (NYSE:MET) price target from $78 to $79
Morgan Stanley analyst Nigel Dally maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $78 to $79.
News & Forecast & Price target & Analyst Ratings & Estimates
Morgan Stanley analyst Nigel Dally maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $78 to $79.
Wells Fargo analyst Elyse Greenspan maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $82 to $83.
Citigroup analyst Michael Ward maintains MetLife (NYSE:MET) with a Buy and raises the price target from $76 to $81.
Morgan Stanley analyst Nigel Dally reiterates MetLife (NYSE:MET) with a Overweight and maintains $78 price target.
RBC Capital Raises Price Target on MetLife (NYSE:MET) to $74 From $70, Maintains Outperform Rating.
MetLife (NYSE:MET) reported Q1 adjusted earningsĀ of $1.52 per share, down from $2.04 a year earlier. Analysts polled by Capital IQ expected $1.86. Total revenue for the quarter ended March 31 was $15.39 billion, slightly down from $15.41 billion a year earlier. In a separate statement, MetLife said it has set a new $3 billion authorization to buy back its shares. The new authorization is in addition to the $202 million remaining under the company’s previous authorization announced in May of last year.
RBC Capital analyst Mark Dwelle maintains MetLife (NYSE:MET) with a Outperform and lowers the price target from $76 to $68.
Wells Fargo analyst Elyse Greenspan maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $72 to $75.
Wells Fargo Adjusts Price Target on MetLife (NYSE:MET) to $72 From $84, Maintains Overweight Rating.
Goldman Sachs analyst Alex Scott maintains MetLife (NYSE:MET) with a Neutral and lowers the price target from $79 to $65.